Developers Can Outperform Producers in the Silver Cycle,

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
191
Developers Can Outperform Producers in the Silver Cycle, and Why New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Is Set to Benefit

Disseminated on behalf of New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) and includes paid advertisement.

- Global supply deficits and rising industrial demand support a long-term case for higher silver prices, though silver remains historically undervalued in real terms, even after recent price appreciation.
- Development-stage companies can offer superior risk-adjusted returns compared with existing producers.
- New Pacific Metals owns two of the world’s largest undeveloped silver deposits, Silver Sand and Carangas.
- Both projects have demonstrated strong economics in technical studies and could jointly produce nearly 19 million ounces per year when developed.

Investors seeking exposure to silver tend to naturally gravitate toward established producers with healthy margins. Yet history suggests that the strongest risk-adjusted returns often come from a different corner of the sector: development-stage companies advancing large, viable deposits toward production. In the current silver market, characterized by supply shortages, robust industrial demand, and long-term underinvestment, developers such as New Pacific Metals (NYSE American: NEWP) (TSX: NUAG) can often provide a clearer path to value creation than miners already in operation.

A recent analysis of global silver developers argues that the metal remains deeply undervalued when adjusted for inflation (https://nnw.fm/Af530 ). While nominal prices briefly touched record highs above US$53/oz this year, the inflation-adjusted high from 1980 would translate to roughly US$187/oz in today’s dollars. That gap underscores how far silver prices remain from past real levels. Compounding this, the gold-to-silver ratio has hovered near 90–100:1 for most of 2025, far above its historical average of about 60:1. By these measures, silver appears relatively inexpensive against both gold and its own long-term pricing.

The supply side tells a similar story. Global silver demand has outpaced supply for five consecutive years, with a projected deficit of 117–149 million ounces in 2025. Industrial use reached a record 681 million ounces in 2024 and continues to rise, driven by solar manufacturing, electric vehicles and electronics. Yet new silver production has been slow to respond. Ore grades have declined more than 50% since 2007, costs of development have risen and output in countries such as the United States, Canada and Australia has fallen sharply from early-2000s levels.

These conditions create an environment where higher silver prices are needed to incentivize new supply. They also highlight an important structural point: most silver is produced as a by-product of mining for other metals. As a result, even substantial increases in silver prices do not necessarily trigger new silver production from existing mines. The shortage of large, undeveloped primary silver projects has become increasingly apparent.

This is where developers, companies with defined deposits advancing toward feasibility, permitting and financing, can offer advantages. They have already completed the highest-risk stage of mining: discovery. Only about one in 1,000 exploration projects becomes an economic deposit. Developers are the survivors of that process, moving through technical studies that determine how and when a project could be built.

Developers often trade at low valuations in the mid-stage “valley” between discovery excitement and the start of construction. During this period, investor attention frequently shifts toward producers with immediate cash flow, leaving development companies undervalued relative to the intrinsic worth of their assets. As developers de-risk their projects, secure permits and publish feasibility studies, value tends to accrete steadily, often sharply as construction nears. Rising metal prices amplify this effect: because a developer’s cost assumptions are fixed in economic models, higher silver prices can dramatically increase project net present value.

Against this backdrop, Canadian exploration and development company New Pacific Metals stands out. The company owns two of the world’s largest undeveloped open-pittable silver deposits, Silver Sand and Carangas. Technical studies published last year showed solid economics for both assets. While neither project is currently producing, their potential combined output, nearly 19 million ounces of silver annually, would exceed that of many established silver companies.

The Silver Sand project is among the most advanced large-scale silver developments globally, with near-surface mineralization suitable for open-pit mining. Carangas offers a different profile: a broad, near-surface silver zone underlain by a substantial gold system, adding optionality in future expansions. The substantial scale of both projects places New Pacific in a rare category: a developer with multiple large deposits capable of supporting long-term production.

The jurisdiction is not without challenges. Bolivia has historically presented complex regulatory and political environments for mining companies, while ranking among the top global silver producers. However, a recent political shift spells good news for the mining sector and New Pacific’s established presence in the country. The inauguration of President Rodrigo Paz last month has reordered the country’s political and economic priorities. Paz outlined a reformist agenda built on “positioning Bolivia in the world,” promoting what he described as “capitalism for everyone,” reducing state bureaucracy, and empowering regional governments, while signaling more collaborative relations with foreign investors.

Meanwhile, structural factors continue to favor higher long-term silver prices. Global solar demand is expected to absorb more than 20% of total silver supply in 2025, up from 10% in 2020. Critical minerals policies in the United States, Canada and Australia are encouraging development of domestic mining capacity, while Chinese production and processing still dominate the global supply chain. As countries push for supply security, large deposits in stable corporate structures become more important.

For investors assessing how to position for the next phase of the silver cycle, the argument for development-stage companies is rooted in timing, scarcity and leverage. Developers offer relatively predictable costs, rising project value as feasibility progresses and significant upside if silver prices continue climbing from historically undervalued real levels. New Pacific Metals sits squarely within that value-creation window. If silver continues moving toward a price level that incentivizes new supply, development-stage assets of this scale may become increasingly central to the sector’s future.

For more information, visit the company’s website at NewPacificMetals.com/welcome.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at  https://nnw.fm/NEWP

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

New Pacific Metals Corp. (NEWP) Stock Research Links

NEWP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Phreesia Announces Q3 Fiscal Year 2025 Financial Results

Updated Category News Views 71

Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...

Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience

Updated Category News Views 374

Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...

Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead

Updated Category News Views 177

Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...

Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025

Updated Category News Views 132

Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....

Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19

Updated Category News Views 154

New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...

Continue Reading